Table 2 Patients’ clinical characteristics and laboratory results at admission
All patients (n = 475) | Survivors (n = 428) | Non-survivors (n = 47) | p-value | |
|---|---|---|---|---|
Presentation symptoms | ||||
Fever | 249 (52.4) | 217 (50.7) | 32 (68.1) | 0.03 |
Cough | 276 (58.1) | 240 (56.1) | 36(76.6) | 0.01 |
Dyspnea | 162 (34.1) | 129 (30.1) | 33 (70.2) | < 0.001 |
Diarrhea | 95 (20) | 92 (21.5) | 3 (6.4) | 0.006 |
Anosmia | 23 (4.8) | 23 (5.4) | 0 | 0.08 |
Initial examination findings | ||||
Pulse rate (/min) | 80 (67–89) | 80 (65–88) | 88 (80–97) | 0.007 |
SpO2 value (%) | 98 (94–99) | 98 (94–99) | 94 (88–99) | 0.006 |
Respiratory rate (/min) | 19 (18–20) | 18 (18–20) | 22 (18–26) | 0.015 |
Blood pressure (mmHg) | ||||
Systolic | 120 (110–130) | 120 (110–130) | 120 (120–130) | 0.871 |
Diastolic | 80 (70–80) | 80 (70–80) | 80 (70–80) | 1 |
Laboratory results at admission | ||||
Serum creatinine (mg/dL) | 1.15 (0.9–1.6) | 1.15 (0.9–1.6) | 1.2 (0.9–1.7) | 0.762 |
Leucocyte count (/mm3) | 6300 (4565–8300) | 6300 (4500–8300) | 6300 (4725–8300) | 0.749 |
Lymphocyte count (/mm3) | 1000 (670–1595) | 1100 (700–1650) | 743 (500–1153) | 0.033 |
Hemoglobin (g/dL) | 12.8 (11.2–15) | 12.8 (11.2–14) | 12.7 (10.9–14.1) | 0.988 |
Platelet count (/mm3) | 201 (158–265) | 201 (162–266) | 183 (131–262) | 0.156 |
Serum CRP levels (mg/L) | 20 (5–57) | 18 (5–49) | 66 (13–150) | 0.001 |
Serum ALT levels (IU/L) | 20 (14–29) | 20 (14–29) | 20 (16–36) | 0.597 |
Serum AST levels (IU/L) | 20 (16–29) | 20 (16–28) | 26 (17–35) | 0.032 |
Serum LDH levels (IU/L) | 238 (189–317) | 227 (186–297) | 344 (250–537) | < 0.001 |
Serum D-dimer (ng/mL) | 386 (201–795) | 373 (200–764) | 480 (211–1290) | 0.54 |
Serum Ferritin (ng/mL) | 354 (130–768) | 296 (113–726) | 630 (239–1523) | 0.011 |
Serum Albumin (g/dL) | 4 (3.5–4.3) | 4 (3.6–4.3) | 3.5 (3.1–4.1) | < 0.001 |
Serum IL-6 (pg/mL) | 0.43 (0.15–1.41) | 0.23 (0.15–1.33) | 3.15 (1–1.9) | 0.016 |
Procalcitonin (ng/mL) | 0.1 (0.05–0.6) | 0.09 (0.04–3.13) | 0.78 (0.18–4.15) | < 0.001 |